Tokyo, June 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061809) titled 'SWITCH-26 Study: A Longitudinal Questionnaire Study on the Impact of Switching to a 26-Week Injectable Therapy on Convenience and Psychological Burden in Patients with Bronchial Asthma' on June 5.

Study Type: Observational

Primary Sponsor: Institute - University of Miyazaki

Condition: Condition - Asthma Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The objective of this study is to longitudinally evaluate changes in convenience and psychological burden in patients with bronchial asthma who switch from conventional biologic therapies to a long-acting injectable therapy administered every 26 weeks. In addition, this study aims to assess temporal changes in patient-reported outcomes, including treatment satisfaction, and to examine the impact of extended dosing intervals on patient-centered outcomes. Basic objectives2 - Others

Eligibility: Age-lower limit - 20 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Patients aged 20 years or older at the time of consent Patients who have been receiving the same biologic therapy (omalizumab, mepolizumab, benralizumab, dupilumab, or tezepelumab) for at least 12 months at the time of consent Patients who switch to a long-acting injectable therapy administered every 26 weeks Patients who provide written informed consent after receiving sufficient explanation of the study Key exclusion criteria - Patients who changed biologic therapy within 12 months prior to consent Patients who received unapproved biologic therapies within 12 months prior to consent Patients who received pharmacological treatment for malignancy within 12 months prior to consent Patients deemed inappropriate for participation by the investigator Target Size - 35

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 02 Month 18 Day Date of IRB - 2026 Year 05 Month 21 Day Anticipated trial start date - 2026 Year 06 Month 01 Day Last follow-up date - 2029 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070018

Disclaimer: Curated by HT Syndication.